Nosisa Sipambo to South Africa
This is a "connection" page, showing publications Nosisa Sipambo has written about South Africa.
Connection Strength
0,124
-
Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa. J Acquir Immune Defic Syndr. 2023 04 01; 92(4):273-280.
Score: 0,021
-
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts. Antivir Ther. 2023 02; 28(2):13596535231168480.
Score: 0,021
-
Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study. J Int AIDS Soc. 2022 01; 25(1):e25870.
Score: 0,020
-
The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J. 2021 Sep 01; 40(9S):S69-S78.
Score: 0,019
-
Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa. AIDS. 2021 05 01; 35(6):971-978.
Score: 0,019
-
Field Evaluation of Performance of Alere and Cepheid Qualitative HIV Assays for Pediatric Point-of-Care Testing in an Academic Hospital in Soweto, South Africa. J Clin Microbiol. 2017 11; 55(11):3227-3235.
Score: 0,014
-
Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa. Glob Health Action. 2013 Jan 24; 6:19248.
Score: 0,010